Brief: Boule Diagnostics Closes BM950 Project, Announces New Portfolio Strategy

Boule Diagnostics AB

12/03/2025 09:11

March 12 (Reuters) - Boule Diagnostics AB BOUL.ST:

CLOSES BM950 PROJECT, ANNOUNCES NEW PORTFOLIO STRATEGY

CLOSES BM950 PROJECT DUE TO RECENTLY IDENTIFIED TECHNICAL ISSUES THAT AFFECTED PROFITABILITY OF PRODUCT

SHUTDOWN OF PROJECT WILL RESULT IN IMPAIRMENT OF INTANGIBLE ASSETS OF SEK 92 MILLION RECOGNISED IN 2024 FINANCIAL STATEMENTS

DECISION DOES NOT IMPACT 2025 GROWTH FORECAST NEGATIVELY

BOSEES TO RETURN TO POSITIVE CASH FLOW IN H2 2025

SHUTDOWN WILL ALSO RESULT IN ABOUT SEK 25 MILLION IN ADDITIONAL RESTRUCTURING COSTS IN FIRST QUARTER OF 2025

WILL FOCUS EXCLUSIVELY ON COLLABORATING WITH LEADING TECHNOLOGY PARTNERS

Source text: ID:nWkr8rXzwx

Further company coverage: BOUL.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))